Kliniczny Szpital Wojewódzki nr 2 im. Św. Jadwigi Królowej w Rzeszowie
109 notices in the register, none open now. 60 contracts awarded, worth €104.2M in all.
Main sectors Medical equipment & pharmaceuticals 85, Construction work 11, Repair & maintenance services 6, Transport services 3, Architecture & engineering services 2, Food & beverages 2
Record
Awards by year
- 2026 5 awards €3.5M
- 2025 44 awards €76.2M
- €1.0M
- €10.0M
- largest, €13.2M
Each dot is one award, placed on its date and sized by its value.
Relations
Who wins with this buyer
- MAGNAPHARM POLAND Sp. z o.o.; Bialmed Sp. z o.o.; Neuca S.A.; Janssen-Cilag Polska sp. z o.o.; „Farmacol- Logistyka” Sp. z o. o.; Urtica Sp. z o.o.; Abbvie Sp. z o.o.; Amgen Sp. z o.o.; ASCLEPIOS S.A. 2 contracts €9,954,769
- FARMACOL-LOGISTYKA Sp. z o.o. 1 contract €15,737,039
- BIOTRONIK POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; BALTON SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; MEDTRONIC POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; ABBOTT MEDICAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; SMT POLONIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; AESCULAP CHIFA SPÓŁKA Z OGR 1 contract €9,916,304
- CSL Behring Sp. z o.o.; „Farmacol- Logistyka” Sp. z o. o.; ASCLEPIOS S.A.; AstraZeneca; Komtur Polska Sp. z o.o.; Roche Polska Sp. z o.o.; Sanofi Spółka z o.o; Takeda Pharma Sp. z o.o. 1 contract €7,330,186
- Janssen-Cilag Polska sp. z o.o.; AstraZeneca; Sanofi Spółka z o.o; Takeda Pharma Sp. z o.o.; Urtica Sp. z o.o. 1 contract €5,392,889
- WARBUD S.A. 1 contract €2,780,126
- Takeda Pharma Sp. z o.o.; Bialmed Sp. z o.o.; CENTRALA FARMACEUTYCZNA CEFARM SA; „Farmacol- Logistyka” Sp. z o. o. 1 contract €2,498,028
- BIOTRONIK POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; MEDTRONIC POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; BOSTON SCIENTIFIC POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; ABBOTT MEDICAL SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; WERFEN POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ; ERBE PO 1 contract €2,378,901
Shares of the 54 awards this buyer made to a named company.
Practice
How it buys
Publishing rhythm
Publishes most in October and November.
Next likely wave: November 2026.
- Typical contract value
- €6,301,887
- Median of the last 4 priced notices
Based on 109 notices over the last 24 months.
What to expect from this buyer
Measured in its busiest sector Medical equipment & pharmaceuticals
- Typical final price against the published estimate
- -51.4%
Medians across the 47 comparable awards this buyer made in this sector over the last 5 years. Each figure uses the awards that publish the dates or values it needs.
Next 90 days
Coming up from this buyer
- tenders announced in advance (last 6 months)
- 0
- contracts due back on the market in the next 90 days
- 19
Scorecard
The buyer in figures
How it runs its calls for tender
- usual bidding window
- 31 days
- of its calls state an estimated value
- 0%
Estimates over its calls for tender of the last 3 years, bidding windows over the last 2. Deadline extensions only where the source updates a notice in place (TED publishes corrections as separate notices, so its buyers show none).
Who wins its contracts
Many suppliers- different companies won its awards
- 53
- of the awards went to the three most frequent winners
- 7%
- of its calls state an estimated value
- 0%
Based on 54 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 1.6
- of those lots received a single tender
- 66%
- of the awards went to companies based in another country
- 2%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Register